C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
01/2003
01/02/2003	EP1268422A1 Indoles for treating diseases that can be treated using thyroid hormones
01/02/2003	EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors
01/02/2003	EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
01/02/2003	EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
01/02/2003	EP1268306A1 Inverted aerosol dispenser
01/02/2003	EP1115716B1 2-phenylpyran-4-one derivatives
01/02/2003	EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
01/02/2003	EP0925286B1 Substituted pyrimidine derivatives and their pharmaceutical use
01/02/2003	EP0751939B9 Naphthylamides as central nervous system agents
01/01/2003	CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent
12/2002
12/31/2002	US6500959 Pyrrolidine derivatives and processes for preparing same
12/31/2002	US6500950 Benzylidenepyrazolones, their preparation and use
12/31/2002	US6500851 Antithrombotic agents
12/31/2002	US6500849 Administering antiinflammatory, antiproliferative, nootropic or antigrowth agents, such as 6-(1-dodecynyl)-2-pyridine-carboxaldehyde and enantiomorphs to mammals; alzheimers disease
12/31/2002	US6500846 2-(4-chlorophenyl)-7-methoxychromen-4-one, as cyclin-dependent kinase inhibitors, used as anticarcinogenic agents or for prophylaxis of neurodegenerative disease
12/31/2002	US6500842 N-((4-chlorophenyl)methyl)-8-hydroxy-7-quinolinecarboxamide administered as viricides against herpes virus
12/31/2002	US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/31/2002	US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/31/2002	CA2075586C Salicyloyl(thio)ether derivatives, their preparation and intermediates for ther preparation
12/27/2002	WO2002102978A2 Human growth hormone antagonists
12/27/2002	WO2002102798A1 Uracil derivative and herbicide composition
12/27/2002	WO2002102797A1 1-methyl-4-(3-ethoxy-9h-thioxanthene-9-ylidene)-piperidine and its use as 5-ht2b and/or h1 antagonist
12/27/2002	WO2002102796A1 Stereoselective method for the preparation of nucleoside analogues
12/27/2002	WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002	WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/27/2002	WO2002102359A2 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/27/2002	WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/27/2002	WO2002036585A3 Process for the preparation of ligands for olefin polymerization catalysts
12/27/2002	CA2449977A1 Human growth hormone antagonists
12/27/2002	CA2449212A1 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/27/2002	CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002	CA2446963A1 Quinazolinediones as antibacterial agents
12/27/2002	CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/26/2002	US20020198381 Herbicidal pyridine compounds
12/26/2002	US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002	US20020198219 2-pyridinamine compositions and related methods
12/26/2002	US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents
12/26/2002	US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/26/2002	US20020198204 Certain fused pyrrolecarboxamides; a new class of GABA brain receptor
12/26/2002	US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
12/26/2002	US20020197562 Photochromic compositions and photochromic ophthalmic articles
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002	CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/24/2002	US6498251 Tetrahydrobenzindole derivatives
12/24/2002	US6498185 Enzyme factor xa inhibitors
12/24/2002	US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498168 Muscarinic antagonists
12/24/2002	US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498164 Such as 1,3-dibenzyl-5-(phenyl- or 2-thienyl-acetyl)barbi-turic acid; malignant hypercalcemia, osteolytic diseases such as paget's disease, osteoporosis, articular rheumatism occurring in knees, shoulders, joints
12/24/2002	US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002	US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile
12/24/2002	US6498156 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use
12/19/2002	WO2002101073A2 Aryl-benzimidazole compounds having antiinfective activity
12/19/2002	WO2002101007A2 Antipathogenic benzamide compounds
12/19/2002	WO2002100974A2 Core guest host system comprising a chromophore in a polycarbonate matrix
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100853A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/19/2002	WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002	WO2002100851A2 Thiophene derivatives as antiviral agents for flavivirus infection
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100848A1 Novel phenylalkyl diamine and amide analogs
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100486A1 Method and apparatus for treating uterine myoma
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002085853A3 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002069972A3 Triazole compounds and the use thereof in the prophylaxis and therapy of neurodegenerative diseases, cerebral trauma and cerebral ischemia
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2002050082A3 Inhibitors of papilloma virus
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193590 Tetra- or hexa-hydroazepine compounds substituted at the 4 position with benzofur-7-yl, indol-7-yl, or benzo(b)thiophen-7-yl; antidepressants
12/19/2002	US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI
12/19/2002	US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002	US20020193407 Modulators of CCR5 chemokine receptor activity
12/19/2002	US20020193390 Pharmaceutical compositions containing an N-(substituted glycyl)-2- cyanopyrrolidine and at least one other antidiabetic agent and their use in inhibiting dipeptidyl peptidase-IV
12/19/2002	US20020193382 Sulfonamide derivatives, their production and use
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002	CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002	CA2450271A1 Novel phenylalkyl diamine and amide analogs
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

1 ... 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 ... 523